- Megan Paquin

Choose the health content that’s right for you, and get it delivered right in your inbox.
The AdventHealth Neuroscience Institute is celebrating a new designation as one of only 20 ELITE GammaTile Centers in the U.S. This recognition comes as the institute’s neurosurgeons and oncologists have successfully completed 10 GammaTile procedures since becoming the first in Central Florida to treat aggressive brain tumors with this advanced technology.
GammaTile Therapy is a novel Surgically Targeted Radiation Therapy (STaRT) for operable brain tumors. Implanted in the last five minutes of brain tumor removal surgery, each bioresorbable, 3D-collagen GammaTile is embedded with radiation sources. GammaTile Therapy delivers a sustained, controlled, therapeutic radiation dose, targeting tumor cells while sparing healthy tissue.

“Our commitment to complete, whole-person neurological care begins with our world-class specialists who consistently seek out leading-edge therapies for our patients,” said Craig Brubaker, vice president of AdventHealth’s Neuroscience Institute. “This milestone exemplifies their dedication, and we are pleased to be able to bring this advanced level of brain care to residents of this community.”
Dr. Melvin Field added, “This innovation is giving our patients a head-start in the fight against brain tumors. With GammaTile, we can immediately and precisely target cancer-involved tissues with a high dose of radiation, potentially extending our patients lives and helping maintain a higher quality of life throughout their treatment.”
In the past 50 years, only seven drugs or devices have been FDA-approved or -cleared to treat brain tumors. The latest advancement in brain tumor treatment, GammaTile Therapy was FDA-cleared in 2018 for recurrent brain tumors, including recurrent high-grade gliomas, glioblastomas, meningiomas and brain metastases. In 2020, the FDA expanded that indication to include newly diagnosed malignant brain tumors. For more information, visit the AdventHealth Neuroscience Institute’s brain tumor program here.
Recent News
On the day of his planned wedding, Mike Rounkles suffered a life-threatening heart attack. Thanks to fast action by Johnson County MED-ACT and AdventHealth Shawnee Mission team members, he received...
A teenager with autism met with the Flight 1 team to tour its helicopter and facilities.
What's your personal why behind your job? AdventHealth President/CEO David Banks shares about when it clicked for him early on in his career with the organization.
A first-of-its-kind report from global consulting firm Charles River Associates shows AdventHealth contributed over $16 billion in economic benefits to Florida in 2023.
Instead of relying on doctor's office visits every few weeks, the health system's new program prompts virtual visits for uncontrolled blood pressure.
AdventHealth is the first in Wesley Chapel to offer HYDROS™ Robotic System: A leading-edge AI-powered platform for Aquablation Therapy to treat BPH, or Benign Prostatic Hyperplasia.
The success of this case underscores the impact of early symptom recognition, coordinated EMS response, and hospital readiness.
AdventHealth South Overland Park has earned The Joint Commission’s Gold Seal of Approval® and the American Heart and Stroke Association’s Heart-Check mark for Primary Stroke Certification.
AdventHealth Zephyrhills honors first responders during EMS Week.
Hear from our doctors and nurses why they love our EMS partners, and join us in saying thank you.
Skin Cancer Awareness Month serves as a crucial reminder of the importance of vigilance in detecting and preventing skin cancer, the most common cancer affecting both men and women in the United...
A former patient of AdventHealth Littleton returned to recognize NICU moms on Mother’s Day.